Autologous hematopoietic stem cell transplantation in Non-Hodgkin's lymphomas - PubMed (original) (raw)
Review
Autologous hematopoietic stem cell transplantation in Non-Hodgkin's lymphomas
Pier Luigi Zinzani. Acta Haematol. 2005.
Abstract
Early studies on high-dose therapy followed by autologous bone marrow transplantation demonstrated the safety and efficacy of this approach in non-Hodgkin's lymphoma (NHL). As the procedure became easier and safer with the introduction of peripheral blood progenitor cells instead of marrow, the popularity of this procedure declined. In the last decade, autologous hematopoietic stem cell transplantation has played an important role in front-line and salvage treatments of indolent and aggressive NHL.
Copyright (c) 2005 S. Karger AG, Basel.
Similar articles
- Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
van Besien K, Margolin K, Champlin R, Forman S. van Besien K, et al. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S54-8. Cancer J Sci Am. 1997. PMID: 9457395 Clinical Trial. - Autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Kessinger A, Nademanee A, Forman SJ, Armitage JO. Kessinger A, et al. Hematol Oncol Clin North Am. 1990 Jun;4(3):577-87. Hematol Oncol Clin North Am. 1990. PMID: 1972701 Review. - Autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.
Bolwell BJ. Bolwell BJ. Semin Oncol. 1994 Aug;21(4 Suppl 7):86-95. Semin Oncol. 1994. PMID: 7916488 Review. - Autologous hematopoietic stem cell transplant in first remission in non-Hodgkin's lymphoma.
Tomblyn M, Winter JN. Tomblyn M, et al. Expert Rev Anticancer Ther. 2003 Jun;3(3):281-94. doi: 10.1586/14737140.3.3.281. Expert Rev Anticancer Ther. 2003. PMID: 12820773 Review. - Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ, Sweetenham JW, Loberiza FR Jr, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A; Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Bierman PJ, et al. J Clin Oncol. 2003 Oct 15;21(20):3744-53. doi: 10.1200/JCO.2003.08.054. Epub 2003 Sep 8. J Clin Oncol. 2003. PMID: 12963703
Cited by
- Plerixafor-based mobilization and mononuclear cell counts in graft increased the risk of engraftment syndrome after autologous hematopoietic stem cell transplantation.
Cao LQ, Wen Q, Liu BN, Zhao ZY, Zhang XH, Xu LP, Chen H, Wang Y, Yu L, Wang FR, Huang XJ, Mo XD. Cao LQ, et al. Blood Sci. 2024 May 16;6(3):e00190. doi: 10.1097/BS9.0000000000000190. eCollection 2024 Jul. Blood Sci. 2024. PMID: 38779304 Free PMC article. - Development of CMV-CD19 bi-specific CAR T cells with post-infusion in vivo boost using an anti-CMV vaccine.
Wang X, Diamond DJ, Forman SJ, Nakamura R. Wang X, et al. Int J Hematol. 2021 Nov;114(5):544-553. doi: 10.1007/s12185-021-03215-6. Epub 2021 Sep 24. Int J Hematol. 2021. PMID: 34561840 Free PMC article. Review. - Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans.
Jensen MC, Popplewell L, Cooper LJ, DiGiusto D, Kalos M, Ostberg JR, Forman SJ. Jensen MC, et al. Biol Blood Marrow Transplant. 2010 Sep;16(9):1245-56. doi: 10.1016/j.bbmt.2010.03.014. Epub 2010 Mar 19. Biol Blood Marrow Transplant. 2010. PMID: 20304086 Free PMC article. Clinical Trial. - Why can't we find a new treatment for SLE?
Eisenberg R. Eisenberg R. J Autoimmun. 2009 May-Jun;32(3-4):223-30. doi: 10.1016/j.jaut.2009.02.006. Epub 2009 Mar 28. J Autoimmun. 2009. PMID: 19329279 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials